BIONANO GENOMICS, INC.

Profile

Company Names

BIONANO GENOMICS, INC.
BIONANO GENOMICS, INC
BIONANOMATRIX INC

Addresses

9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO, CA 92121

9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO, CA 92121

9640 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO, CA 92121

9640 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO, CA 92121

9640 TOWNE CENTRE DRIVE, SAN DIEGO, CA 92121

3701 MARKET STREET, 4TH FLOOR, PHILADELPHIA, PA 19104

Phone Numbers

(858) 888-7600
(609) 818-0054

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER HEALTH CARE, PHARMACEUTICALS

Year Incorporated:

2007

State Incorporated:

DELAWARE

Total Amount Raised:

$238,431,762.00

Number of Funding Rounds:

12
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
12
2024-07-08 
$20,000,001.00 
$20,000,001.00 
$0.00 
 
11
2024-05-24 
$20,000,000.00 
$20,000,000.00 
$0.00 
Equity, Debt 
10
2023-10-13 
$35,000,000.00 
$35,000,000.00 
$0.00 
Debt 
9
2021-10-18 
$41,850,386.00 
$41,850,386.00 
$0.00 
Equity 
8
2019-03-14 
$2,500,000.00 
$11,500,000.00 
$9,000,000.00 
Equity 
7
2014-09-09 
$68,443,451.00 
$68,443,451.00 
$0.00 
Equity 
6
2014-06-12 
$5,000,500.00 
$6,139,997.00 
$1,139,497.00 
Debt 
5
2013-12-11 
$15,000.00 
$15,000.00 
$0.00 
 
4
2013-09-17 
$10,001,000.00 
$13,663,054.00 
$3,662,054.00 
Debt 
3
2012-06-20 
$11,573,201.00 
$13,939,494.00 
$2,366,293.00 
Equity 
2
2011-03-15 
$23,265,909.00 
$23,265,909.00 
$0.00 
Equity 
1
2010-04-14 
$782,314.00 
$4,000,000.00 
$3,217,686.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DAVID 
L. 
BARKER 
DIRECTOR
DAVID 
L. 
BARKER, PH.D. 
DIRECTOR
MARK 
 
BORODKIN 
EXECUTIVE OFFICER
DARREN 
 
CAI, PH.D. 
DIRECTOR
HAN 
 
CAO 
EXECUTIVE OFFICER
ALKA 
 
CHAUBEY 
EXECUTIVE OFFICER
ALKA 
 
CHAUBEY, PH.D., FACMG 
EXECUTIVE OFFICER
JONATHAN 
 
DIXON 
EXECUTIVE OFFICER
EDWARD 
L. 
ERICKSON 
EXECUTIVE OFFICER, DIRECTOR
ERIK 
R. 
HOLMLIN 
EXECUTIVE OFFICER, DIRECTOR
R. 
ERIK 
HOLMLIN 
EXECUTIVE OFFICER, DIRECTOR
ROBERT 
ERIK 
HOLMLIN 
EXECUTIVE OFFICER, DIRECTOR
R. ERIK 
 
HOLMLIN, PH.D. 
EXECUTIVE OFFICER, DIRECTOR
JOEL 
 
JUNG 
EXECUTIVE OFFICER
JOEL 
R. 
JUNG 
EXECUTIVE OFFICER
GULSEN 
 
KAMA 
EXECUTIVE OFFICER
YVONNE 
 
LINNEY 
DIRECTOR
YVONNE 
 
LINNEY, PH.D. 
DIRECTOR
LORRAINE 
G. 
LOPRESTI 
EXECUTIVE OFFICER
ALBERT 
 
LUDERER 
DIRECTOR
ALBERT 
A. 
LUDERER 
DIRECTOR
ALBERT 
 
LUDERER, PH.D. 
DIRECTOR
ALBERT 
A. 
LUDERER, PH.D. 
DIRECTOR
HANNAH 
 
MAMUSZKA 
DIRECTOR
GARTH 
 
MONROE 
EXECUTIVE OFFICER
MARK 
 
OLDAKOWSKI 
EXECUTIVE OFFICER
JASON 
 
PRIAR 
EXECUTIVE OFFICER
ALEKSANDAR 
 
RAJKOVIC 
DIRECTOR
ALEKSANDAR 
 
RAJKOVIC, M.D., PH.D. 
DIRECTOR
WARREN 
 
ROBINSON 
EXECUTIVE OFFICER
SOHEIL 
 
SHAMS 
EXECUTIVE OFFICER
RICHARD 
 
SHIPPY 
EXECUTIVE OFFICER
CHRISTOPHER 
 
STEWART 
EXECUTIVE OFFICER
CHRISTOPHER 
 
TWOMEY 
DIRECTOR
KRISTIINA 
 
VUORI 
DIRECTOR
KRISTIINA 
 
VUORI, M.D., PH.D. 
DIRECTOR
MIKE 
 
WARD 
EXECUTIVE OFFICER
TRACY 
 
WARREN 
DIRECTOR
VINCENT 
 
WONG 
DIRECTOR
VINCENT 
 
WONG, J.D., M.B.A. 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
DECLINE TO DISCLOSE 
 
2024-07-08 
D
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
DECLINE TO DISCLOSE 
Equity, Debt 
2024-05-24 
D
OTHER HEALTH CARE 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
DECLINE TO DISCLOSE 
Debt 
2023-10-13 
D
OTHER HEALTH CARE 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
DECLINE TO DISCLOSE 
Equity 
2021-10-18 
D
PHARMACEUTICALS 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
NOT APPLICABLE 
Equity 
2019-03-14 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-09-09 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2014-06-12 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
 
2013-12-11 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2013-09-17 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-06-20 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-03-15 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2010-04-14 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
H.C. WAINWRIGHT + CO., LLC
375
NONE
0
CANACCORD GENUITY LLC